Keywords: pharmacyclics, radiation, sensitizer, begun, phase, ib/ii, trial

Pharmacyclics' Radiation Sensitizer

Article | 05 February 1996

- Pharmacyclics has begun a Phase Ib/II trial of its radiation sensitizer gadolinium-texaphyrin (Gd-Tex) in patients with metastatic tumors to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Pharmacyclics

Go to company listing